Introduction
Emodin (3-methyl-1,6,8-trihydroxyanthraquinone), a traditional herb medicine, is a natural anthraquinone and an active constituent occurring in Rheum palmatum. 1, 2 It is believed that the hydroxyl groups in position 1 and 8 of an anthraquinone ring effect the biological action of a compound. 3 Recent pharmacological studies have revealed a number of the biological activities of emodin including an anticancer, antibacterial, anti-inflammatory effect. [4] [5] [6] It exerts an antiproliferative effect in many cancer cell lines. 7 There have been a few speculated mechanisms to explain these bioactivities such as an inhibition of cell growth, 8, 9 a disruption of cell cycle, 10, 11 and an induction of an apotosis, [12] [13] [14] although the mechanisms of emodin are still not clear. Recent study showed that emodin could suppress the protein tyrosine kinase encoded from HER-2/neu protooncogene which is frequently observed in patients with breast cancer. 15, 16 Tyrosine protein kinases (PTKs) play important roles in signal conduction pathways that control celluar functions such as proliferation and differentiation resulting from a tyrosine phosphorylation. 17 A number of proto-oncogenes such as HER-2/neu are related to PTKs which are frequently observed in tumors. 18 Particularly, uncontrolled expression of the HER-2/neu proto-oncogene happens in as many as 30% of breast cancer patients. 19 Emodin has been demonstrated to be a tyrosine kinase inhibitor that can suppress the activity of HER-2/neu protooncogene by blocking tyrosine phosphorylation during a signaling between ATP of the second messenger and a protein in the tumor cells. [20] [21] [22] Thus, we postulated that if a limited structural modification of emodin, like an introduction of iodine, exerts a negligible effect on its inhibition of tyrosine, then radioiodine labeled emodin also has a possibility to visualize breast cancer.
In order to investigate radioiodine labeled emodin as a potent breast cancer imaging agent, 2-[ on human breast cancer cells (MDA-MB-231 and MCF-7) which express HER-2/neu tyrosine kinase was carried out.
Results and Discussion
Both the 2-iodoemodin (2) and 2-[ was susceptible to the volume of the peracetic acid and the reaction temperature that is tabulated in Table 1 .
As shown in Table 1 , the optimal condition was 50 μL of peracetic acid, a 10 min reaction time and a room temperature reaction, whereas heating the reaction mixture ( Table 2 .
The cellular uptakes of 
Experiment Section
All chemicals were purchased from Sigma-Aldrich Co. All solvents were of an analytical grade and used without further purification. Thin layer chromatography and column chromatography were performed using silica gel 60 F 254 and silica gel 60 (0.063-0.200 mm, 70-230 mesh ASTM), respectively (MERCK). Melting points were measured on a MEL-TEMP II device. The Cell Culture. Both of the breast carcinoma MCF-7 and MDA-MB-231 cell lines were obtained from American Type Culture Collection (ATCC). Cells were grown in Dulbecco's Modified Essential Medium (Gibco) with 1.5 g/ L sodium bicarbonate supplemented with 10% fetal bovine serum (FBS) and 100 mg/mL of penicillin-streptomycin (Gibco). Cells were maintained as monolayers in a humidified 5% CO 2 atmosphere, normally in T75 flasks (Falcon). The cells were trypsinated in the T75 flasks at a 80-90% confluence using (0.05% trypsin/0.02% EDTA) and were then suspended in DMEM with 10% FBS to the desired density, normally 2 × 10 5 cells/mL. Cell growth status and viability was monitored by an inverted phase contrast microscopy. Trypan blue exclusion was also used to assess the viability. 
2-Iodoemodin (2)
. 100 mg (0.37 mmol) of emodin and 10 mL of 0.01 M sodium iodide solution were dissolved in 20 mL of ethanol, and then 2.0 mL of 0.5 M H 3 PO 4 and 10.0 mL of 32% peracetic acid were added to the reaction mixture. It was stirred for 15 minutes at room temperature. After 1 mL of 0.048 M sodium hydrogen sulfite was added to the reaction mixture, 2 mL of 0.06 M sodium hydrogen carbonate was also added to quench the reaction and it was stirred for a further 5 minutes. It was poured into 50 mL of saturated NaCl solution and extracted with 50 mL of dichloromethane twice. The combined organic phases were dried over anhydrous sodium sulfate. After a filtration, solvent was removed by a rotary evaporation. Column chromatography of the residue gave 56 mg (0.14 mmol) of 2. 
